Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» osteoarthritis
osteoarthritis
Flexion nabs FDA OK for its potential blockbuster osteoarthritis drug, triggering new buyout buzz
Endpoints
Mon, 10/9/17 - 09:34 am
Flexion
FDA
osteoarthritis
M&A
Zilretta
Cara tries hard to spin the data, but key PhIIb pain study fails and shares slide south
Endpoints
Fri, 06/30/17 - 09:59 am
Cara Therapeutics
clinical trials
CR845
osteoarthritis
With an FDA decision looming, Flexion touts new data spotlighting a safety edge for osteoarthritis drug
Endpoints
Mon, 06/12/17 - 09:49 am
FDA
Flexion
Zilretta
osteoarthritis
Eli Lilly-backed Symic raises $30M round as it preps for a pivotal trial
Endpoints
Tue, 05/23/17 - 08:23 am
Eli Lilly
Symic
clinical trials
osteoarthritis
matrix biology
Aratana: Osteoarthritis drug for dogs could be a 'blockbuster'
Bizjournals.com
Tue, 03/14/17 - 04:36 pm
animal health
Aratana
osteoarthritis
osteoarthritis in dogs
Entyce
Top Biotech Stocks With FDA Decisions in 2017
Motley Fool
Fri, 03/3/17 - 09:42 am
FDA
Flexion
Zilretta
knee pain
osteoarthritis
neratinib
Puma Biotechnology
breast cancer
Portola
betrixaban
bloodthinners
‘Sleepy’ Bedford biotech Anika wakes up investors with recent success
Bizjournals.com
Sat, 06/4/16 - 06:22 pm
Anika Therapeutics
osteoarthritis
Orthovisc
Monovisc
viscosupplements
Flexion's pain drug comes through in Phase III after a prior pivotal failure
Fierce Biotech
Wed, 02/17/16 - 09:39 pm
Flexion
painkillers
osteoarthritis
FX006
Ampio Announces Top-Line Results of the Double-Blind Multiple Intra-Articular Injections (STRUT) Study of Ampion™ in Patients with Moderate to Severe Osteoarthritis of the Knee
Yahoo/PR Newswire
Wed, 02/25/15 - 07:30 am
Ampio Pharmaceuticals
osteoarthritis
Ampion
Osteoarthritis biotech Carbylan swings for a $75M IPO
Fierce Biotech
Mon, 01/26/15 - 08:14 am
Carbylan
osteoarthritis
IPOs
Hydros-TA
FDA lifts hold on Flexion's lead drug
Yahoo/Reuters
Mon, 12/1/14 - 07:33 pm
FDA
Flexion
FX006
osteoarthritis
Kindred Biosciences Falls on Disappointing CereKin Data
Yahoo/Zacks.com
Mon, 08/25/14 - 09:56 am
Kindred Biosciences
CereKin
animal health
osteoarthritis
Ampio: The Freezer Killed My Osteoarthritis Drug
TheStreet.com
Thu, 08/21/14 - 11:26 am
osteoarthritis
Ampio Pharmaceuticals
Ampion
Xoma to stop testing drug as arthritis treatment
Yahoo/Reuters
Tue, 03/4/14 - 10:23 pm
Xoma
gevokizumab
osteoarthritis
This Week in Biotech: 2 FDA Approvals and 3 Clinically Impressive Studies
Motley Fool
Sun, 03/2/14 - 11:59 am
Myalept
leptin deficiency
lipodystrophy
Astra Zeneca
Bristol-Myers Squibb
Anika
Monovisc
osteoarthritis
osteoarthritis of the knee
Ampio Pharmaceuticals Starts Final Study for Osteoarthritis Treatment
Motley Fool
Thu, 01/16/14 - 11:30 am
Ampio Pharmaceuticals
osteoarthritis
Ampion
Horizon obtains US rights to arthritis drug Vimovo
Yahoo/AP
Tue, 11/19/13 - 07:59 am
vivmo
Horizon Pharma
osteoarthritis
rheumatoid arthritis
Rough market day for Nektar, while Pharmacyclics and Regeneron soar
Marketwatch
Fri, 09/27/13 - 08:37 am
Nektar
Pharmacyclics
Regeneron
osteoarthritis
NKTR-181
ibrutinib
XOMA completes enrollment in Phase 2 POC Gevokizumab trial
Yahoo/Fly on the Wall
Mon, 07/22/13 - 11:28 am
Xoma
gevokizumab
osteoarthritis
Merck says now anticipates odanacatib filing in 2014
Yahoo/Fly on the Wall
Fri, 02/1/13 - 10:55 am
Merck
Odanacatib
osteoarthritis
Pages
« first
‹ previous
1
2
3
4
next ›
last »